Integrated Core Strategies (US) LLC 13D/13G Filings for Nektar Therapeutics (NKTR)

Integrated Core Strategies (US) LLC 13D and 13G filings for Nektar Therapeutics:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-07-03
2:07 pm
Purchase
2025-06-27 13G Nektar Therapeutics
NKTR
Integrated Core Strategies (US) LLC 932,863
5.400%
932,863increase
(New Position)
Filing